Why NanoVibronix's Stock Is Trading Higher Today

NanoVibronix NAOV shares are trading higher on Tuesday after the company announced its UroShield received FDA authorization for entry into the U.S.

NanoVibronix is engaged in the manufacturing of noninvasive biological response-activating devices that target wound healing and pain therapy, without the assistance of medical professionals.

The primary products of the company include WoundShield, which is patch-based therapeutic ultrasound device to facilitate tissue regeneration and wound healing by using ultrasound to increase local capillary perfusion and tissue oxygenation; PainShield, which is a disposable patch-based therapeutic ultrasound technology to treat pain, muscle spasm and joint contractures; and UroShield ,which is an ultrasound-based product designed to prevent bacterial colonization and biofilm in urinary catheters, increase antibiotic efficacy and decrease pain.

NanoVibronix shares were trading up 110.24% at $1.24 on Tuesday at the time of publication. The stock has a 52-week high of $3.50 and a 52-week low of 54 cents.